Outlook Therapeutics, Inc. (OTLK) Reports Material Event to SEC
Filing Details Outlook Therapeutics, Inc. (NASDAQ:OTLK) filed a Form 8-K with the Securities and Exchange Commission on June 26, 2026, disclosing a material event. Market Context…
Read more
